Position in CYTK
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$440,517
+$200,144 QoQ
Shares Held
5,171
+41.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#320
of 477 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MML INVESTORS SERVICES, LLC holds $86,570,832 across 61 Biotechnology names. CYTK ranks #39 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
38,907 | $19,326,274 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,117 | $11,296,674 | |
| 3 | ARGX |
Argenx SE
|
6,825 | $6,332,030 | |
| 4 | EXEL |
Exelixis, Inc.
|
73,531 | $4,000,821 | |
| 5 | INSM |
INSMED Inc
|
32,823 | $3,499,588 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,949 | $2,994,947 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
11,712 | $2,822,240 | |
| 8 | RPRX |
Royalty Pharma plc
|
49,942 | $2,800,247 |
All Filings in CYTK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $440,517 | 5,171 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $240,373 | 3,647 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $307,660 | 4,842 | Shares | Defined | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||